{"id":3493,"date":"2025-09-05T16:58:26","date_gmt":"2025-09-05T07:58:26","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3493"},"modified":"2025-09-05T16:58:26","modified_gmt":"2025-09-05T07:58:26","slug":"OKUSAKA-Takuji","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3493","title":{"rendered":"Takuji Okusaka EN"},"template":"","class_list":["post-3493","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Takuji Okusaka","familyName_eg":"Okusaka","has_jp_name":true,"name_jp":"\u5965\u5742\u3000\u62d3\u5fd7","researcher_photo":1550,"participated_in":["1","4"],"degree":"MD, PhD","position":"Chief - Department of Hepatobiliary and Pancreatic Oncology","eg_position":"Chief - Department of Hepatobiliary and Pancreatic Oncology","facilities":3399,"department":["17"],"speciality":"Chemotherapy","eg_speciality":"Chemotherapy","background":"<h2><strong>Dr. Takuji Okusaka's Story<\/strong><\/h2>\r\n<p>Dr. Okusaka specializes in chemotherapy for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors.<br \/>\r\nHe has been committed to developing better treatments to prolong patients' prognosis and improve their quality of life.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Development of novel therapies for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 66px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Chair, Committee for Revision of Clinical Practice Guideline for Pancreatic Cancer<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Chair, Committee for Revision of Clinical Practice Guideline for Biliary tract Cancer<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Member of the Committee for the Development of LCSGJ ICC Guidelines<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Evaluation Committee Member of Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Chemotherapy<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Member of the Japanese Society of Internal Medicine<br \/>\r\nBoard Certified Member of the Japanese Society of Gastroenterology<br \/>\r\nBoard Certified Member of the Japan Biliary Association<br \/>\r\nBoard Certified Expert in Pancreatology<\/p>","eg_background":"<h2><strong>Dr. Takuji Okusaka's Story<\/strong><\/h2>\r\n<p>Dr. Okusaka specializes in chemotherapy for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors.<br \/>\r\nHe has been committed to developing better treatments to prolong patients' prognosis and improve their quality of life.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Development of novel therapies for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 66px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Chair, Committee for Revision of Clinical Practice Guideline for Pancreatic Cancer<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Chair, Committee for Revision of Clinical Practice Guideline for Biliary tract Cancer<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Member of the Committee for the Development of LCSGJ ICC Guidelines<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td width=\"637\" style=\"width: 77.6204%;\">Evaluation Committee Member of Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Chemotherapy<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Member of the Japanese Society of Internal Medicine<br \/>\r\nBoard Certified Member of the Japanese Society of Gastroenterology<br \/>\r\nBoard Certified Member of the Japan Biliary Association<br \/>\r\nBoard Certified Expert in Pancreatology<\/p>","researcher_outerlink1":"","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3399"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}